{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:46:43Z","timestamp":1788216403582,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To test the non\u2010inferiority of bipolar transurethral vaporization of the prostate (TUVP) compared to GreenLight laser (GL) photoselective vaporization of the prostate (PVP) for reduction of benign prostatic hyperplasia\u2010related lower urinary tract symptoms in a randomized trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Eligible patients with prostate volumes of 30\u201380\u00a0mL were randomly allocated to GL\u2010PVP (\n                      <jats:italic>n =<\/jats:italic>\n                      58) or bipolar TUVP (\n                      <jats:italic>n =<\/jats:italic>\n                      61). Non\u2010inferiority of symptom score (International Prostate Symptom Score [IPSS]) at 24\u00a0months was evaluated. All peri\u2010operative variables were recorded and compared. Urinary (IPSS, maximum urinary flow rate and post\u2010void residual urine volume) and sexual (International Index of Erectile Function\u201015) outcome measures were evaluated at 1, 4, 12 and 24\u00a0months. Need for retreatment and complications, change in PSA level and health resources\u2010related costs of both procedures were recorded and compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline and peri\u2010operative variables were similar in the two groups. At 1, 4, 12 and 24\u00a0months, 117, 116, 99 and 96 patients, respectively, were evaluable. Regarding urinary outcome measures, there was no significant difference between the groups. The mean \u00b1\n                      <jats:sc>sd<\/jats:sc>\n                      IPSS at 1 and 2\u00a0years was 7.1 \u00b1 3 and 7.9 \u00b1 2.9 (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.8), respectively, after GL\u2010PVP and 6.3 \u00b1 3.1 and 7.2 \u00b1 2.8, respectively, after bipolar TUVP (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.31). At 24\u00a0months, the mean difference in IPSS was 0.7 (95% confidence interval \u22120.6 to 2.3;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.6). The median (range) postoperative PSA reduction was 64.7 (25\u201399)% and 65.9 (50\u201399)% (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.006) after GL\u2010PVP, and 32.1 (28.6\u201389.7)% and 39.3 (68.8\u201390.5)% (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.005) after bipolar TUVP, at 1 and 2\u00a0years, respectively. After 2\u00a0years, retreatment for recurrent bladder outlet obstruction was reported in eight (13.8%) and 10 (16.4%) patients in the GL\u2010PVP and bipolar TUVP groups, respectively (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.8). The mean estimated cost per bipolar TUVP procedure was significantly lower than per GL\u2010PVP procedure after 24\u00a0months (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In terms of symptom control, bipolar TUVP was not inferior to GL\u2010PVP at 2\u00a0years. Durability of the outcome needs to be tracked. The greater cost of GL\u2010PVP compared with bipolar TUVP is an important concern.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.14926","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T20:50:06Z","timestamp":1571259006000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A randomized trial comparing bipolar transurethral vaporization of the prostate with GreenLight laser\u00a0(xps\u2010180watt) photoselective vaporization of the prostate for treatment of small to moderate benign prostatic obstruction: outcomes after 2 years"],"prefix":"10.1111","volume":"125","author":[{"given":"Fady K.","family":"Ghobrial","sequence":"first","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shoma","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-0161","authenticated-orcid":false,"given":"Ahmed M.","family":"Elshal","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Laymon","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr","family":"El\u2010Tabey","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Nabeeh","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Shokeir","sequence":"additional","affiliation":[{"name":"Urology Department, Urology and Nephrology Center Mansoura University Mansoura Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.03.058"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.03.039"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.06.017"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2016.04.006"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.054"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-014-1384-4"},{"key":"e_1_2_7_8_1","unstructured":"Online currency tables.2018; Available at:https:\/\/www.xe.com\/currencytables. Accessed June 2018"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1639-8"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01300-0"},{"key":"e_1_2_7_11_1","unstructured":"GravasTB BachmannA DrakeMet al.Guidelines on the Management of Non\u2010Neurogenic Male Lower Urinary Tract Symptoms (LUTS) incl. Benign Prostatic Obstruction (BPO).2015. Available at:https:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf. Accessed July 2018"},{"key":"e_1_2_7_12_1","unstructured":"NICE\u2010guidance.GreenLight XPS for treating benign prostatic hyperplasia. Lower urinary tract symptoms.2016. Available at:nice.org.uk\/guidance\/mtg29. Accessed August 2018"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/089277901750161917"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09433.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.03.072"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500631"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.041"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1163-7"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2013.0356"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.12954\/PI.12006"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.12.031"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-014-1667-4"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22108"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2012.06038.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000173075.62504.73"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.05.031"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.10.040"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06683.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta12350"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.14926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.14926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.14926","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.14926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:40:50Z","timestamp":1761759650000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.14926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1111\/bju.14926"],"URL":"https:\/\/doi.org\/10.1111\/bju.14926","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"2019-11-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}